International Journal of Biological Macromolecules · 2019 · 31 citations · 51 references
MedicineOncologyPharmacologyBiomedical ImagingMolecular ImagingMolecular OncologyMolecular Imaging In OncologyRadiopharmaceutical DesignTargeted Cancer TherapyTargeted Imaging AgentsTheranostic ImagingTumor ImagingAnkyrin Repeat DomainsCancer ImagingMolecular Contrast ImagingMolecular Imaging Of CancerMolecular Imaging Probe DesignTargeted Molecular Imaging AgentsTumor Uptake KineticsTumor Uptake Mechanisms
-Ec1 demonstrated the highest imaging contrast in preclinical models than any other EpCAM-imaging agent tested so far. In conclusion, DARPin Ec1 in combination with a non-residualizing label is a promising probe for imaging EpCAM expression a few hours after injection.
51
Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks et al. · Journal of Clinical Oncology · 2013 · 4.1K citations · Full text
Identification of Pancreatic Cancer Stem Cells
Chenwei Li, David G. Heidt, Piero Dalerba et al. · Cancer Research · 2007 · 3.4K citations · Full text
Medicine, Cell Biology, Oncology +17
Metastatic patterns in adenocarcinoma
Kenneth R. Hess, Gauri R. Varadhachary, Sarah Taylor et al. · Cancer · 2006 · 819 citations · Full text
Pancreatic Ductal Adenocarcinoma
Ioannis T. Konstantinidis, Andrew L. Warshaw, Jill N. Allen et al. · Annals of Surgery · 2012 · 422 citations · Full text